Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets  (full – 2003)                                           


Cannabinoids for gastrointestinal diseases: potential therapeutic applications. (abst – 2003)                               


Involvement of cannabinoid receptors in gut motility and visceral perception (full – 2004)                                 


Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.                                                      (abst – 2007)


Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans (full – 2008)










Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                       


Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non- erosive gastro-oesophageal reflux disease.                                                                   (abst – 2010)


Beyond acid suppression: new pharmacologic approaches for treatment of GERD. (abst – 2010)                                 


The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility.                    (full – 2012)


Localization of mGluR5, GABA(B) , GABA(A) , and cannabinoid receptors on the vago- vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study.                                                                                       (abst – 2012)


Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease.                                                (abst – 2012)


Share a link for